US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 24.300
  • -0.170-0.69%
Close Jun 13 16:00 ET
  • 24.300
  • 0.0000.00%
Post 16:00 ET
1.67BMarket Cap-5522P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
23.65%14.46M
-15.54%3.19M
-29.84%3.04M
145.27%4.38M
Operating revenue
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
23.65%14.46M
-15.54%3.19M
-29.84%3.04M
145.27%4.38M
Cost of revenue
Gross profit
Operating expense
10.97%51.32M
65.69%216.33M
68.62%59.75M
67.99%55.44M
77.10%54.9M
48.56%46.25M
68.87%130.56M
63.46%35.43M
75.70%33M
62.57%31M
Selling and administrative expenses
17.23%16.45M
22.23%59.83M
40.48%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
50.92%48.95M
22.85%10.72M
23.94%10.25M
51.70%11.14M
-General and administrative expense
17.23%16.45M
22.23%59.83M
40.48%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
50.92%48.95M
22.85%10.72M
23.94%10.25M
51.70%11.14M
Research and development costs
8.24%34.86M
91.76%156.5M
80.82%44.7M
75.23%39.87M
100.06%39.72M
125.50%32.21M
81.84%81.61M
90.79%24.72M
116.42%22.75M
69.37%19.85M
Operating profit
23.13%-31.79M
-63.10%-189.35M
-68.74%-54.42M
-67.17%-50.08M
-63.41%-43.5M
-51.63%-41.35M
-76.93%-116.1M
-80.09%-32.25M
-107.36%-29.96M
-54.02%-26.62M
Net non-operating interest income expense
126.45%4.8M
345.23%10.74M
200.94%5.46M
170.10%3.17M
-136.00%-9K
453.50%2.12M
184.22%2.41M
338.24%1.81M
246.93%1.17M
103.14%25K
Non-operating interest income
92.01%5.62M
143.26%14M
137.82%6.28M
100.15%3.99M
-10.57%812K
1,243.58%2.93M
4,696.67%5.76M
4,372.88%2.64M
8,195.83%1.99M
3,847.83%908K
Non-operating interest expense
1.61%821K
-2.42%3.26M
-0.73%820K
-0.37%814K
-7.02%821K
-1.22%808K
12.06%3.34M
0.73%826K
-0.73%817K
7.81%883K
Other net income (expense)
115.67%71K
-7.03%-594K
381.58%183K
-457.00%-714K
157.35%390K
-300.88%-453K
-555K
38K
29.87%200K
-11,433.33%-680K
Gain on sale of security
115.67%71K
-7.03%-594K
381.58%183K
-457.00%-714K
157.35%390K
-300.88%-453K
---555K
--38K
29.87%200K
-11,433.33%-680K
Income before tax
32.18%-26.91M
-56.87%-179.21M
-60.47%-48.78M
-66.61%-47.63M
-58.09%-43.12M
-41.81%-39.68M
-66.82%-114.24M
-61.82%-30.4M
-89.39%-28.59M
-50.92%-27.28M
Income tax
43.37%-350K
195.60%1.46M
176.19%320K
1,054.62%2.27M
-15.66%-517K
-47.49%-618K
8.36%-1.52M
43.85%-420K
42.65%-238K
-179.38%-447K
Net income
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
Net income continuous Operations
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
Minority interest income
Net income attributable to the parent company
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
Basic earnings per share
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
-42.32%-3.8
-60.32%-1.01
-62.71%-0.96
-21.62%-0.9
Diluted earnings per share
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
-42.32%-3.8
-60.32%-1.01
-62.71%-0.96
-21.62%-0.9
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M23.65%14.46M-15.54%3.19M-29.84%3.04M145.27%4.38M
Operating revenue 298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M23.65%14.46M-15.54%3.19M-29.84%3.04M145.27%4.38M
Cost of revenue
Gross profit
Operating expense 10.97%51.32M65.69%216.33M68.62%59.75M67.99%55.44M77.10%54.9M48.56%46.25M68.87%130.56M63.46%35.43M75.70%33M62.57%31M
Selling and administrative expenses 17.23%16.45M22.23%59.83M40.48%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M50.92%48.95M22.85%10.72M23.94%10.25M51.70%11.14M
-General and administrative expense 17.23%16.45M22.23%59.83M40.48%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M50.92%48.95M22.85%10.72M23.94%10.25M51.70%11.14M
Research and development costs 8.24%34.86M91.76%156.5M80.82%44.7M75.23%39.87M100.06%39.72M125.50%32.21M81.84%81.61M90.79%24.72M116.42%22.75M69.37%19.85M
Operating profit 23.13%-31.79M-63.10%-189.35M-68.74%-54.42M-67.17%-50.08M-63.41%-43.5M-51.63%-41.35M-76.93%-116.1M-80.09%-32.25M-107.36%-29.96M-54.02%-26.62M
Net non-operating interest income expense 126.45%4.8M345.23%10.74M200.94%5.46M170.10%3.17M-136.00%-9K453.50%2.12M184.22%2.41M338.24%1.81M246.93%1.17M103.14%25K
Non-operating interest income 92.01%5.62M143.26%14M137.82%6.28M100.15%3.99M-10.57%812K1,243.58%2.93M4,696.67%5.76M4,372.88%2.64M8,195.83%1.99M3,847.83%908K
Non-operating interest expense 1.61%821K-2.42%3.26M-0.73%820K-0.37%814K-7.02%821K-1.22%808K12.06%3.34M0.73%826K-0.73%817K7.81%883K
Other net income (expense) 115.67%71K-7.03%-594K381.58%183K-457.00%-714K157.35%390K-300.88%-453K-555K38K29.87%200K-11,433.33%-680K
Gain on sale of security 115.67%71K-7.03%-594K381.58%183K-457.00%-714K157.35%390K-300.88%-453K---555K--38K29.87%200K-11,433.33%-680K
Income before tax 32.18%-26.91M-56.87%-179.21M-60.47%-48.78M-66.61%-47.63M-58.09%-43.12M-41.81%-39.68M-66.82%-114.24M-61.82%-30.4M-89.39%-28.59M-50.92%-27.28M
Income tax 43.37%-350K195.60%1.46M176.19%320K1,054.62%2.27M-15.66%-517K-47.49%-618K8.36%-1.52M43.85%-420K42.65%-238K-179.38%-447K
Net income 32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M-93.13%-28.35M-49.77%-26.83M
Net income continuous Operations 32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M-93.13%-28.35M-49.77%-26.83M
Minority interest income
Net income attributable to the parent company 32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M-93.13%-28.35M-49.77%-26.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M-93.13%-28.35M-49.77%-26.83M
Basic earnings per share 52.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3-42.32%-3.8-60.32%-1.01-62.71%-0.96-21.62%-0.9
Diluted earnings per share 52.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3-42.32%-3.8-60.32%-1.01-62.71%-0.96-21.62%-0.9
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg